Overall rank by patents
#18,542
of 50,000 tracked assignees
USPTO PatentsView assignee record - 15 granted patents across 10 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
According to USPTO PatentsView, DNA ranks #18,542 of 50,000 tracked US assignees by granted-patent volume, with 15 patents across 10 technology areas.
USPTO PatentsView assignee plate
Corpus R18542 · Foreign Corporation #18,542 · 15 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: DIC Corporation (tokyo) (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
DNA Script · this assignee
41 score
3D Lighting Innovati… · lowest
7 score
What this shows DNA Script stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, SPAN-YRS, BOOK-RICH. Volume places it #18,542 of 50,000; Innovation Score 40.5/100 sits in the top 35% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is DIC Corporation (tokyo) (±0 grants).
DNA Script has been granted 15 US utility patents between 2020 and 2025, placing DNA Script at #18,542 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.5 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, DNA Script is one of the more focused assignees in the PatentsView dataset. By volume, DNA sits between DIC Corporation (tokyo) (15 patents, rank #18,529) and Dri-steem Corporation (15 patents, rank #18,537) - the closest US assignees by grant volume. The composite Innovation Score of 40.5/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Historical data spans 2020 through 2025, with 15 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. DNA Script's 13.5 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 10 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
DIC CORPORATION (TOKYO)
15 patents
DIPHARMA FRANCIS S.R.L.
15 patents
DISH Network Corporation
15 patents
DL CHEMICAL CO., LTD.
15 patents
DONGGUAN YULONG TELECOMMUNICATION TECH CO., LTD.
15 patents
DOSELOGIX, LLC
15 patents
DPIX, LLC
15 patents
DRI-STEEM Corporation
15 patents
DNA Script
15 patents
What this shows DNA holds 15 patents at rank #18,533, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #18,533 in granted patent volume.
Other assignees with the most granted patents in DNA's primary technology class.
DNA's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 35% higher than 65% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 13.3% |
| 2021 | 2 | 13.3% |
| 2022 | 1 | 6.7% |
| 2023 | 1 | 6.7% |
| 2024 | 5 | 33.3% |
| 2025partial year | 4 | 26.7% |
Top 10 of 10 technology areas
Overall rank by patents
#18,542
of 50,000 tracked assignees
40.5 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.